Status:
RECRUITING
Improving Communication and Adherence in Black Breast Cancer Survivors (Sisters Informing Sisters)
Lead Sponsor:
Virginia Commonwealth University
Collaborating Sponsors:
Georgetown University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The purpose of this study is to test an evidence-based intervention designed to increase adherence to systemic therapy in Black women compared to enhanced usual care.
Detailed Description
Black women continue to experience worse breast cancer outcomes, which may be due to inadequate adherence to systemic therapies that can be improved via patient-centered communication. We developed an...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Self-identify as Black
- Newly diagnosed (\~4 weeks post-definitive surgery and prior to initiation of adjuvant chemotherapy or endocrine therapy) patients (stage I-III)
- Eligible for chemotherapy or endocrine therapy according to NCCN guidelines, but have not initiated systemic therapy
- Ability to read and speak English
- Ability to provide meaningful consent as determined by trained study personnel and/or a member of the patient's care team
- No prior cancer treatment (other than skin cancer) in the two years preceding enrollment
- Physicians Must be a license doctor of study patient(s)
- Ability to speak English
Exclusion
Key Trial Info
Start Date :
March 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2026
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT05334732
Start Date
March 1 2021
End Date
February 28 2026
Last Update
October 29 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States, 20007
2
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
3
Massey Cancer Center
Richmond, Virginia, United States, 23298